Root Financial Partners
TNXP icon

Root Financial Partners’s Tonix Pharmaceuticals TNXP Stock Holding History

Root Financial Partners’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.33K Buy
+137
New +$1.62K ﹤0.01% 2816
2026
Q2 		– Sell
-60
Closed -$825 – 2941
2026
Q1 		$825 Buy
+60
New +$924 ﹤0.01% 2678

Other funds holding TNXP

Essex Investment Management
Essex Investment Management Boston, Massachusetts $675M AUM 61.81% 1-Year Est. Return
Acorn Wealth Advisors
Acorn Wealth Advisors Grand Blanc, Michigan $407M AUM 14.44% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
CNBT
Cornerstone National Bank & Trust Palatine, Illinois $309M AUM 7.69% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
STRS Ohio
STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return
Essential Partners
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
SJS Investment Consulting
SJS Investment Consulting Sylvania, Ohio $993M AUM 16.29% 1-Year Est. Return

Root Financial Partners's TNXP Position: Q3 2026 in Review

Root Financial Partners opened a new position in Tonix Pharmaceuticals (TNXP) in Q3 2026: 137 shares worth $1.33K. The stake represents ﹤0.01% of the portfolio and ranks #2816 among its holdings. This is a return to the name: Root Financial Partners previously reported a position in TNXP as recently as Q1 2026.

Root Financial Partners first reported a position in TNXP in Q1 2026 and has held it in 2 quarters since. 22 funds tracked by Wall St. Rank hold TNXP as of Q3 2026.

  • Root Financial Partners held 137 shares of Tonix Pharmaceuticals worth $1.33K as of Q3 2026.
  • Tonix Pharmaceuticals was a new Root Financial Partners position in Q3 2026.
  • Tonix Pharmaceuticals made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #2816 holding.
  • Root Financial Partners first reported a position in Tonix Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 22 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q3 2026.

Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.